Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $53.11 USD
Change Today +0.32 / 0.61%
Volume 181.3K
ABAX On Other Exchanges
As of 8:10 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

abaxis inc (ABAX) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/30/15 - $66.89
52 Week Low
06/2/14 - $40.96
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ABAXIS INC (ABAX)

abaxis inc (ABAX) Related Businessweek News

No Related Businessweek News Found

abaxis inc (ABAX) Details

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide blood constituent measurements for clinicians worldwide. It operates in two segments, Medical Market and Veterinary Market. The company offers Piccolo Xpress chemistry analyzers with blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents. It also provides VetScan VS2, a chemistry, electrolyte, immunoassay, and blood gas analyzer delivering results from a sample of whole blood, serum, or plasma; VetScan HM5; and VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, as well as reagent kits for veterinary applications. In addition, the company offers VetScan VSpro that assists the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, disseminated intravascular coagulation evaluation, hepatic disease, monitoring therapy, and disease progression states; VetScan VSpro coagulation test to evaluate prothrombin and the activated partial thromboplastin times; VetScan VSpro fibrinogen test for in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; and i-STAT that delivers blood gas, electrolyte, chemistry, and hematology results. Further, it provides VetScan Canine Heartworm rapid test to detect dirofilaria immitis in canine whole blood, serum, or plasma; VetScan Canine Lyme rapid test to detect Borrelia burgdorferi in canine whole blood, serum, or plasma; Vetscan Canine Parvovirus rapid test to detect canine parvovirus antigen in feces; and VetScan Giardia rapid test to detect Giardia cyst antigens in canine feces, as well as veterinary reference laboratory diagnostic and consulting services. Abaxis, Inc. sells its products through direct sales force and independent distributors. The company was founded in 1989 and is headquartered in Union City, California.

abaxis inc (ABAX) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $478.1K
Chief Financial Officer, Vice President of Fi...
Total Annual Compensation: $258.5K
Chief Operations Officer
Total Annual Compensation: $258.5K
Chief Technology Officer
Total Annual Compensation: $258.5K
Compensation as of Fiscal Year 2014.

abaxis inc (ABAX) Key Developments

Abaxis, Inc. Presents at Stifel 2015 Dental & Veterinary Conference, May-27-2015 10:20 AM

Abaxis, Inc. Presents at Stifel 2015 Dental & Veterinary Conference, May-27-2015 10:20 AM. Venue: The Peninsula Hotel, New York, New York, United States. Speakers: Ross Taylor, Vice President of Business Development and Investor Relations.

Abaxis, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-12-2015 10:00 AM

Abaxis, Inc. Presents at Bank of America Merrill Lynch 2015 Health Care Conference, May-12-2015 10:00 AM. Venue: Encore at the Wynn, 3131 S Las Vegas Blvd, Las Vegas, Nevada, United States. Speakers: Clinton H. Severson, Chairman, Chief Executive Officer and President.

Abaxis, Inc. Declares Quarterly Dividend, Payable on June 18, 2015

Abaxis, Inc. announced that its Board of Directors declared an increase in the quarterly dividend from $0.10 to $0.11 per common share, to be paid on June 18, 2015, to all shareholders of record as of the close of business on June 4, 2015. This represents a 10% increase compared to the prior quarterly dividend.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABAX:US $53.11 USD +0.32

ABAX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Rad Laboratories Inc $144.37 USD +2.01
Heska Corp $31.70 USD -0.62
Millennium Healthcare Inc $0.03 USD -0.0015
PetMed Express Inc $16.69 USD +0.08
VCA Inc $52.46 USD -0.20
View Industry Companies

Industry Analysis


Industry Average

Valuation ABAX Industry Range
Price/Earnings 57.8x
Price/Sales 5.9x
Price/Book 5.4x
Price/Cash Flow 43.5x
TEV/Sales 5.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABAXIS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at